US Partners
US Partners (also referenced as U.S. Venture Partners / USVP) is a California-based venture capital firm that invests as a co-investor in healthcare and medical device companies, with documented participation in Nervonik's Series B and Okami Medical's financing round.
- Company typePrivate
- Founded-
- HeadquartersCalifornia, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
US Partners firmographics
Firmographics- Name
- US Partners
- Website
- https://uspartners.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- US Partners (also referenced as U.S. Venture Partners / USVP) is a California-based venture capital firm that invests as a co-investor in healthcare and medical device companies, with documented participation in Nervonik's Series B and Okami Medical's financing round.
- Ownership category
- akta.pro rank
US Partners industry classification
Industry- Product category
- Venture Capital / Private Equity
- NAICS
- Funds, Trusts, and Other Financial Vehicles (525), Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
Keywords
Where US Partners is headquartered
LocationHeadquarters
- HQ city
- California
- HQ country
- United States
- HQ region
- North America
Markets served
US Partners business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Others
US Partners product offering
Product offeringCore offering
US Partners (also referenced as U.S. Venture Partners / USVP) is a private investment firm that participates as a financial investor in equity financing rounds of growth-stage healthcare and medical-technology companies. The provided sources document its participation in Nervonik's $52.5M Series B in April 2026 and Okami Medical's $45M financing in November 2025; no additional products or services are described in the input.
Differentiator
Problem solved
Functional benefit
Products and services
- Equity investment in growth-stage medical device companies Provision of growth-stage equity capital alongside healthcare-focused co-investors, used by clinical and early-commercial medical device companies to fund development and commercialization milestones. Documented transactions include a $52.5M Series B for Nervonik and a $45M financing for Okami Medical.
- Participation in Okami Medical financing round Co-investment alongside Gilde Healthcare and Vensana Capital in a $45M financing for Okami Medical, supporting commercialization and clinical programs for vascular embolization devices.
Companies that use US Partners
Customer profileIdeal customer profiles1 record
US Partners technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
US Partners competitors and assessment
Company assessmentBroad incumbents
- OrbiMed: Large, established healthcare-only investment platform spanning venture, growth, and public equities. Comparable as a healthcare-dedicated investor operating across the same medtech subsector, though at significantly greater scale than US Venture Partners.
- Baird Capital: Diversified private investment platform with a dedicated healthcare team. Comparable as it participates in growth-stage healthcare rounds with a similar mandate to US Venture Partners, though operating a broader multi-sector portfolio.
Direct peers
- Gilde Healthcare: Dedicated healthcare and medtech investor active in growth-stage rounds. Comparable as a healthcare sector specialist that US Venture Partners co-invests with, operating a similar thesis around commercial-stage medical technologies.
- Versant Ventures: Healthcare-dedicated venture capital firm investing across biotech, medtech, and digital health. Comparable as a sector specialist operating at the same growth-stage medtech intersection US Venture Partners targets.
- Lumira Ventures: Healthcare-dedicated venture capital firm. Comparable as a healthcare sector specialist that has co-invested with US Venture Partners in medical device rounds, with overlapping target geographies and stages.
- HealthQuest Capital: Growth-stage healthcare and medical technology investor. Comparable as a healthcare-specialist growth fund pursuing commercial-stage medtech companies, with overlapping stage and sector focus to US Venture Partners.
- Vensana Capital: Medical technology-focused growth investor. Comparable as a medtech-only specialist participating in US Venture Partners' co-investment rounds and pursuing similar commercial-stage medical device opportunities.
- Amzak Health: Healthcare-focused venture and growth investor. Directly comparable as it leads/co-invests in commercial-stage medical device and healthcare rounds alongside funds like US Venture Partners, and shares a similar sector-specialist mandate.
- RA Capital Management: Healthcare-only investment firm active across private and public markets. Comparable as a healthcare-focused investor with growth-stage medtech exposure similar to US Venture Partners' positioning.
- Elevage Medical Technologies: Medical device-focused investment platform. Comparable as a medtech-specialist investor co-participating alongside US Venture Partners in peripheral nerve stimulation and adjacent device financings.
Market position
Customer concentration
US Partners social profiles
Digital presenceUS Partners financial estimates
Financial estimateRevenue estimate
Valuation estimate
US Partners leadership team
Management profileNumber of profiles
US Partners funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
US Partners M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about US Partners
What does US Partners do?
US Partners (also referenced as U.S. Venture Partners / USVP) is a private investment firm that participates as a financial investor in equity financing rounds of growth-stage healthcare and medical-technology companies. The provided sources document its participation in Nervonik's $52.5M Series B in April 2026 and Okami Medical's $45M financing in November 2025; no additional products or services are described in the input.
Is US Partners a public or private company?
US Partners is a private company. It is classified as unknown and is currently operating.
When was US Partners founded?
US Partners was founded in -1. It employs 11 to 50 people.
Where is US Partners based?
US Partners is headquartered in California, United States, in the North America region.
Who are US Partners's main competitors?
Broad incumbents on record are OrbiMed and Baird Capital. Direct peers are Gilde Healthcare, Versant Ventures, Lumira Ventures, HealthQuest Capital, Vensana Capital, Amzak Health, RA Capital Management and Elevage Medical Technologies.
Does US Partners have an API?
No public API is recorded for US Partners.
What industry is US Partners in?
US Partners's product category is Venture Capital / Private Equity. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 525 and its SIC code is 6282.